Illumina (ILMN) has been making notable movements in the stock market, predominantly outpacing its competitors. Recent acquisitions by
Decheng Capital LLC and
Principal Securities Inc. have boosted its position. Also, the stock witnessed new investments from
Kingsview Wealth Management LLC and
Victory Capital Management Inc. However, some firms including
Brown Advisory Inc and
QRG Capital Management Inc have reduced their holdings. Illumina's recent
Q1 earnings had mixed results, with revenues surpassing expectations, but the adjusted operating loss widened. Its global expansion continues despite macroeconomic challenges. It recently submitted its
Form 10 registration statement for GRAIL divestiture, which has been approved by the
European Commission. The company has also appointed
Ankur Dhingra as Chief Financial Officer,
Jakob Wedel as Chief Strategy and Corporate Development Officer, and
Anna Richo has joined the Board of Directors. Explosive growth in the biotech industry paved the way for Illumina's success, but its stock has seen a decrease in value over the past three years.
Illumina ILMN News Analytics from Wed, 01 Nov 2023 07:00:00 GMT to Thu, 30 May 2024 22:07:34 GMT -
Rating 2
- Innovation 5
- Information 6
- Rumor -2
